financetom
Business
financetom
/
Business
/
PNM Resources Receives New Mexico Regulatory OK for 410 Megawatt Solar, Battery Expansion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
PNM Resources Receives New Mexico Regulatory OK for 410 Megawatt Solar, Battery Expansion
May 31, 2024 5:05 AM

07:38 AM EDT, 05/31/2024 (MT Newswires) -- PNM Resources ( PNM ) said Friday that the New Mexico Public Regulation Commission has approved an application by its Public Service Company of New Mexico subsidiary for 410 megawatts of solar and battery storage capacity to be added by summer 2026.

The application was submitted in October after record-high demand by PNM customers in the summers of 2022 and 2023.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Jaguar Health to Detail Regulatory Strategy for Antidiarrheal Drug for Cancer Patients Next Week
Jaguar Health to Detail Regulatory Strategy for Antidiarrheal Drug for Cancer Patients Next Week
Aug 5, 2024
02:06 PM EDT, 08/05/2024 (MT Newswires) -- Jaguar Health ( JAGX ) Monday said it will explore ways to win additional regulatory approvals for its crofelemer antidiarrheal drug in patients with certain types of cancers, but failed to meet the primary endpoint across all tumor types. Crofelemer currently is approved by the US Food and Drug Administration to help control...
BioAffinity Raises Nearly $1.8 Million From Offerings
BioAffinity Raises Nearly $1.8 Million From Offerings
Aug 5, 2024
01:50 PM EDT, 08/05/2024 (MT Newswires) -- BioAffinity Technologies ( BIAF ) said Monday it raised a total of under $1.8 million from a registered direct offering, concurrent private placement, and warrant inducement. The company said it issued 1,041,667 shares at $1.25 apiece to three existing accredited investors who exercised outstanding warrants for proceeds of $1.3 million. The investors also...
Church & Dwight Analysts Slash Their Forecasts After Q2 Results
Church & Dwight Analysts Slash Their Forecasts After Q2 Results
Aug 5, 2024
Church & Dwight Co., Inc ( CHD ). reported upbeat second-quarter adjusted EPS results on Friday. Church & Dwight ( CHD ) reported quarterly earnings of 93 cents per share which beat the analyst consensus estimate of 84 cents per share. The company reported quarterly sales of $1.511 billion which met the analyst consensus estimate, according to data from Benzinga...
ITeos Therapeutics Names David Feltquate Chief Medical Officer
ITeos Therapeutics Names David Feltquate Chief Medical Officer
Aug 5, 2024
01:43 PM EDT, 08/05/2024 (MT Newswires) -- ITeos Therapeutics ( ITOS ) said Monday it appointed David Feltquate chief medical officer. Feltquate most recently served as chief medical officer at Palleon Pharmaceuticals. Price: 15.82, Change: -0.75, Percent Change: -4.53 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved